Correlation among genotype, phenotype, and biochemical markers in Gaucher disease: implications for the prediction of disease severity

Phil Whitfield, Paul Nelson, Peter C Sharp, Colleen A Bindloss, Caroline Dean, Elaine M Ravenscroft, Beverley A Fong, Michael J Fietz, John J Hopwood, Peter J Meikle

Research output: Contribution to journalArticlepeer-review

46 Citations (Scopus)


Gaucher disease is a lysosomal storage disorder characterized by a deficiency of the enzyme acid beta-glucosidase. The clinical manifestations of Gaucher disease are highly variable, and although certain genotypes are often associated with mild or severe symptoms, a defined correlation between genotype and phenotype does not exist. Identification of biochemical markers characteristic of pathology may be of use in predicting the progression of the disease state. In this study the relationship among genotype, glycolipid substrates, lysosomal proteins, and the clinical manifestations of Gaucher disease has been evaluated. Plasma glycolipids were analyzed using electrospray ionization-tandem mass spectrometry. Lysosomal-associated membrane protein-1 (LAMP-1) and saposin C were determined by immunoquantification. Patients with Gaucher disease were shown to have an increased 16:0-glucosylceramide/16:0-lactosylceramide ratio and elevated concentrations of LAMP-1 and saposin C in plasma. A general relationship was found to exist among the 16:0-glucosylceramide/16:0-lactosylceramide ratio, LAMP-1 and saposin C levels, and patient phenotype, providing a refinement of the genotype-phenotype correlation. These findings have major implications for the diagnosis, prediction of disease severity, and monitoring of therapy in patients with Gaucher disease.
Original languageEnglish
Pages (from-to)46-55
Number of pages10
JournalMolecular Genetics and Metabolism
Issue number1
Publication statusPublished - Jan 2002


  • Adolescent
  • Adult
  • Antigens, CD
  • Biological Markers
  • Child
  • Child, Preschool
  • Disease Progression
  • Female
  • Gaucher Disease
  • Genotype
  • Glucosylceramides
  • Glycoproteins
  • Humans
  • Infant
  • Lactosylceramides
  • Lysosome-Associated Membrane Glycoproteins
  • Male
  • Membrane Glycoproteins
  • Middle Aged
  • Phenotype
  • Predictive Value of Tests
  • Saposins


Dive into the research topics of 'Correlation among genotype, phenotype, and biochemical markers in Gaucher disease: implications for the prediction of disease severity'. Together they form a unique fingerprint.

Cite this